These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9871609)

  • 1. Novel bisphosphonate inhibitors of phosphoglycerate kinase.
    Caplan NA; Pogson CI; Hayes DJ; Blackburn GM
    Bioorg Med Chem Lett; 1998 Mar; 8(5):515-20. PubMed ID: 9871609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate inhibition of phosphoglycerate kinase: quantitative structure-activity relationship and pharmacophore modeling investigation.
    Kotsikorou E; Sahota G; Oldfield E
    J Med Chem; 2006 Nov; 49(23):6692-703. PubMed ID: 17154500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel inhibitors of 3-phosphoglycerate kinase.
    Hickey MJ; Coutts IG; Tsang-Tan LL; Pogson CI
    Biochem Soc Trans; 1995 Nov; 23(4):607S. PubMed ID: 8654792
    [No Abstract]   [Full Text] [Related]  

  • 4. Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N(6)-substituted adenosine.
    Bressi JC; Choe J; Hough MT; Buckner FS; Van Voorhis WC; Verlinde CL; Hol WG; Gelb MH
    J Med Chem; 2000 Nov; 43(22):4135-50. PubMed ID: 11063610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies with inhibitors of the glycolytic enzyme phosphoglycerate kinase for potential treatment of cardiovascular and respiratory disorders.
    Mcharg J; Littlechild JA
    J Pharm Pharmacol; 1996 Feb; 48(2):201-5. PubMed ID: 8935172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bisubstrate analog induces unexpected conformational changes in phosphoglycerate kinase from Trypanosoma brucei.
    Bernstein BE; Williams DM; Bressi JC; Kuhn P; Gelb MH; Blackburn GM; Hol WG
    J Mol Biol; 1998 Jun; 279(5):1137-48. PubMed ID: 9642090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase.
    De Schutter JW; Zaretsky S; Welbourn S; Pause A; Tsantrizos YS
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5781-6. PubMed ID: 20801032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphonate inhibitors of glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate kinase.
    Li YK; Byers LD
    Biochim Biophys Acta; 1993 Jun; 1164(1):17-21. PubMed ID: 8518293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of MK-401 against Fasciola hepatica: inhibition of phosphoglycerate kinase.
    Schulman MD; Ostlind DA; Valentino D
    Mol Biochem Parasitol; 1982 Mar; 5(3):133-45. PubMed ID: 7088033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling of substrate binding to 3-phosphoglycerate kinase with analogues of 3-phosphoglycerate.
    Vas M
    Eur J Biochem; 1990 Dec; 194(2):639-45. PubMed ID: 2269289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of bisphosphonate acidity on the activity of a thymidylyltransferase.
    Beaton SA; Jiang PM; Melong JC; Loranger MW; Mohamady S; Veinot TI; Jakeman DL
    Org Biomol Chem; 2013 Sep; 11(33):5473-80. PubMed ID: 23857455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orientation of 1,3-bisphosphoglycerate analogs bound to phosphoglycerate kinase.
    Jakeman DL; Ivory AJ; Blackburn GM; Williamson MP
    J Biol Chem; 2003 Mar; 278(13):10957-62. PubMed ID: 12509431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of a series of aromatic bisphosphonates.
    Barney RJ; Wasko BM; Dudakovic A; Hohl RJ; Wiemer DF
    Bioorg Med Chem; 2010 Oct; 18(20):7212-20. PubMed ID: 20832326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly potent bisphosphonate ligands for phosphoglycerate kinase.
    Jakeman DL; Ivory AJ; Williamson MP; Blackburn GM
    J Med Chem; 1998 Nov; 41(23):4439-52. PubMed ID: 9804684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the kinetics of reversible enzyme inhibition by a general algebraic method. Application to multisite inhibition of the phosphoglycerate kinase from Trypanosoma brucei.
    Puech J; Callens M; Willson M
    J Enzyme Inhib; 1998; 14(1):27-47. PubMed ID: 10520758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD73 inhibition by purine cytotoxic nucleoside analogue-based diphosphonates.
    Dumontet C; Peyrottes S; Rabeson C; Cros-Perrial E; Géant PY; Chaloin L; Jordheim LP
    Eur J Med Chem; 2018 Sep; 157():1051-1055. PubMed ID: 30176535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An NMR analysis of the binding of inhibitors to yeast phosphoglycerate kinase.
    Boyle HA; Fairbrother WJ; Williams RJ
    Eur J Biochem; 1989 Oct; 184(3):535-43. PubMed ID: 2806237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bishomoisoprenoid triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase.
    Wills VS; Metzger JI; Allen C; Varney ML; Wiemer DF; Holstein SA
    Bioorg Med Chem; 2017 Apr; 25(8):2437-2444. PubMed ID: 28302510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation of bisphosphonate inhibition of a vacuolar proton-pumping pyrophosphatase.
    Szabo CM; Oldfield E
    Biochem Biophys Res Commun; 2001 Sep; 287(2):468-73. PubMed ID: 11554752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphate group of 3-phosphoglycerate accounts for conformational changes occurring on binding to 3-phosphoglycerate kinase. Enzyme inhibition and thiol reactivity studies.
    Tompa P; Hong PT; Vas M
    Eur J Biochem; 1986 Feb; 154(3):643-9. PubMed ID: 3948871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.